Warning: The NCBI web site requires JavaScript to function. more...
Latency: the hidden HIV-1 challenge.
Marcello A.
Retrovirology. 2006 Jan 16;3:7. Review.
Related citations
HIV-1 latency in actively dividing human T cell lines.
Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B.
Retrovirology. 2008 Apr 25;5:37.
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T, McArthur J, Siliciano RF.
Annu Rev Immunol. 2000;18:665-708. Review.
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
Hermankova M, Siliciano JD, Zhou Y, Monie D, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.
J Virol. 2003 Jul;77(13):7383-92.
Experimental approaches to the study of HIV-1 latency.
Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF.
Nat Rev Microbiol. 2007 Feb;5(2):95-106. Review.
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF.
Science. 1997 Nov 14;278(5341):1295-300.
The challenge of viral reservoirs in HIV-1 infection.
Blankson JN, Persaud D, Siliciano RF.
Annu Rev Med. 2002;53:557-93. Review.
Regulation of human immunodeficiency virus-1 latency and its reactivation.
Verdin E.
Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF.
Nature. 1997 May 8;387(6629):183-8.
Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
Ikeda T, Shibata J, Yoshimura K, Koito A, Matsushita S.
J Infect Dis. 2007 Mar 1;195(5):716-25. Epub 2007 Jan 18.
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
Colin L, Van Lint C.
Retrovirology. 2009 Dec 4;6:111. Review.
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.
Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J.
Nat Rev Microbiol. 2009 Nov;7(11):798-812. Review.
Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.
Mujtaba S, Zhou MM.
Methods. 2011 Jan;53(1):97-101. Epub 2010 Sep 7. Review.
A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF.
Hopkins HIV Rep. 1998 Jan;10(1):1, 5-6, 11.
Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V, De Walque S, Van Lint C.
Subcell Biochem. 2007;41:371-96. Review.
Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD, Moore B, Cloyd MW.
Virology. 1996 Nov 1;225(1):196-212.
Hide-and-seek: the challenge of viral persistence in HIV-1 infection.
Geeraert L, Kraus G, Pomerantz RJ.
Annu Rev Med. 2008;59:487-501. Review.
Molecular mechanisms of HIV-1 proviral latency.
Bisgrove D, Lewinski M, Bushman F, Verdin E.
Expert Rev Anti Infect Ther. 2005 Oct;3(5):805-14. Review.
The multifactorial nature of HIV-1 latency.
Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano RF.
Trends Mol Med. 2004 Nov;10(11):525-31. Review.
Curing HIV: Pharmacologic approaches to target HIV-1 latency.
Choudhary SK, Margolis DM.
Annu Rev Pharmacol Toxicol. 2011 Feb 10;51:397-418. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on